Literature DB >> 7412802

A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure.

R A Goldstein, E R Passamani, R Roberts.   

Abstract

The hemodynamic effects of dobutamine were compared with those of digoxin in six patients with cardiac failure within 24 hours of onset of acute myocardial infarction. Dobutamine (8.5 microgram per kilogram of body weight per minute) was given intravenously for 30 minutes and then discontinued until hemodynamics returned toward base line. Digoxin (12.5 microgram per kilogram) was then given intravenously, and hemodynamics were recorded for 90 minutes. Dobutamine decreased left ventricular filling pressure (from 22.3 to 9.8 mm Hg, P < 0.02) and systemic vascular resistance (1686 +/- 188 to 1259 +/- 108 dynes . sec . cm-5), and increased cardiac index (from 2.4 to 3.2 liters per minute per square meter of body-surface area, P < 0.005) and stroke work index (from 24.6 to 36.6 g . m per square meter, P < 0.02), without changing heart rate or arterial pressure. In contrast, digoxin had no effect on filling pressure (18.3 versus 17.0) and only a slight effect on cardiac index (2.2 versus 2.4, P < 0.05) and stroke work index (21.9 versus 27.6, P < 0.05). Thus, dobutamine markedly increased cardiac output, decreased filling pressure, and relieved pulmonary congestion. Digoxin, did not affect preload or afterload.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7412802     DOI: 10.1056/NEJM198010093031503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

Review 1.  Digoxin after myocardial infarction. Does it have a role?

Authors:  G D Johnston
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 2.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

Review 3.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

4.  Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

Authors:  A C Tweddel; R G Murray; D Pearson; W Martin; I Hutton
Journal:  Br Heart J       Date:  1982-04

5.  Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.

Authors:  H Drexler; H Löllgen; H Just
Journal:  Klin Wochenschr       Date:  1981-06-15

Review 6.  Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.

Authors:  I Crozier; H Ikram
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

7.  Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction.

Authors:  M B Fowler; A D Timmis; J P Crick; R Vincent; D A Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

8.  Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.

Authors:  H Stopfkuchen; D Schranz; R Huth; B K Jüngst
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 9.  Combination of positive inotropic and vasodilating substances in congestive heart failure.

Authors:  I Cantelli; D Bracchetti
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 10.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.